Perret C - Search Results

1

Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J. Desbois-Mouthon C, et al. Among authors: perret c. Oncogene. 2001 Jan 11;20(2):252-9. doi: 10.1038/sj.onc.1204064. Oncogene. 2001. PMID: 11313952

2

New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.

Cadoret A, Ovejero C, Terris B, Souil E, Lévy L, Lamers WH, Kitajewski J, Kahn A, Perret C. Cadoret A, et al. Among authors: perret c. Oncogene. 2002 Nov 28;21(54):8293-301. doi: 10.1038/sj.onc.1206118. Oncogene. 2002. PMID: 12447692

3

c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor.

Cadoret A, Desbois-Mouthon C, Wendum D, Leneuve P, Perret C, Tronche F, Housset C, Holzenberger M. Cadoret A, et al. Among authors: perret c. Int J Cancer. 2005 Apr 20;114(4):668-72. doi: 10.1002/ijc.20805. Int J Cancer. 2005. PMID: 15609331

4

Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.

Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C. Cadoret A, et al. Among authors: perret c. Cancer Res. 2001 Apr 15;61(8):3245-9. Cancer Res. 2001. PMID: 11309273

5

Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.

Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A, Vandewalle A, Perret C. Saadi-Kheddouci S, et al. Among authors: perret c. Oncogene. 2001 Sep 20;20(42):5972-81. doi: 10.1038/sj.onc.1204825. Oncogene. 2001. PMID: 11593404

6

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.

Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Cunha AS, Bioulac-Sage P, Perret C. Zucman-Rossi J, et al. Among authors: perret c. Oncogene. 2007 Feb 1;26(5):774-80. doi: 10.1038/sj.onc.1209824. Epub 2006 Sep 11. Oncogene. 2007. PMID: 16964294

7

Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.

Renard CA, Fourel G, Bralet MP, Degott C, De La Coste A, Perret C, Tiollais P, Buendia MA. Renard CA, et al. Among authors: perret c. Oncogene. 2000 May 18;19(22):2678-86. doi: 10.1038/sj.onc.1203617. Oncogene. 2000. PMID: 10851067

8

Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.

Cavard C, Terris B, Grimber G, Christa L, Audard V, Radenen-Bussiere B, Simon MT, Renard CA, Buendia MA, Perret C. Cavard C, et al. Among authors: perret c. Oncogene. 2006 Jan 26;25(4):599-608. doi: 10.1038/sj.onc.1208860. Oncogene. 2006. PMID: 16314847

9

Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.

Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J. Legoix P, et al. Among authors: perret c. Oncogene. 1999 Jul 8;18(27):4044-6. doi: 10.1038/sj.onc.1202800. Oncogene. 1999. PMID: 10435629

10

Overexpression of human beta TrCP1 deleted of its F box induces tumorigenesis in transgenic mice.

Belaïdouni N, Peuchmaur M, Perret C, Florentin A, Benarous R, Besnard-Guérin C. Belaïdouni N, et al. Among authors: perret c. Oncogene. 2005 Mar 24;24(13):2271-6. doi: 10.1038/sj.onc.1208418. Oncogene. 2005. PMID: 15735746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters